Genomics & Precision Medicine Solution
Your iDeal Partner to Transform Sick Care to Healthcare
Healthcare is undergoing a qualitative shift towards prevention and early diagnosis, with genetic testing playing a crucial role in this evolution. These tests contribute to understanding the genetic factors associated with diseases, enabling physicians to devise personalized and effective treatment plans. Genetic testing helps identify genetic risks, directing efforts towards improving quality of life and preventing diseases. This transformation signifies a paradigm shift from traditional medical care to a more holistic approach to healthcare.
Genedrive® MT-RNR1
New revolutionary Point of Care Genetic test (GeneDrive) that give result in 26 minutes and used in NICU & PICU to detect a gene mutation (MT-RNR1) in neonates before administering Aminoglycosides Antibiotics (e.g. Gentamicin) in serious infections (e.g. Neonatal Sepsis). If the patient tests positive for this mutation, he/she will develop irreversible Aminoglycosides Induced Hearing Loss (AGHL) even from one dose!! Thus, alternative antibiotic should be used in such case.
This is the only Point of Care test in the world for this purpose, it is CE-IVD certified, and is now used in UK & other European countries and is recommended by several clinical guidelines including NICE.
Together from Sick Care to Healthcare